MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: KleidungDarkweb mixerAntwortenAntworten: Darkweb mixer <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:10 Uhr</div>[url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702 ]Zoya Demidenko[/url]: Researcher in Oncology Science [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey= ]Zoya Demidenko[/url] is a notable investigator affiliated with the Unit of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she conducted research at the National Institutes of Health and New York Medical College, building a strong background in life science study. Her scientific output covers several pivotal domains, among them the PI3K/AKT/mTOR signaling cascade, cell cycle regulation, cellular aging, and cancer science. To date, she has authored more than 46 peer-reviewed papers, which have accumulated upwards of 4,100 references — a indicator to the impact of her work. Among her most notable discoveries lies in understanding the processes of cellular senescence. Her studies demonstrated that when the cell cycle is blocked while cellular expansion persists, cells enter senescence. Significantly, [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053 ]Zoya Demidenko[/url] established that this process is inhibited by medication using agents such as rapamycin. [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053 ]Zoya Demidenko[/url] has furthermore contributed considerably to cancer treatment investigation, notably in the domain of selective cell protection — a approach intended to safeguarding non-cancerous cells from chemotherapy while leaving cancer cells vulnerable. This method offers considerable hope for lowering the side effects of oncological therapy. Across her professional journey, Demidenko has collaborated with leading scientists internationally, among them Dr. Mikhail Blagosklonny. Her work is published in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Possessing an h-index of 33, [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/ ]Zoya Demidenko[/url] is recognized as a widely cited contributor in modern cancer science, with her discoveries keep to guide our understanding of how cells age, resist therapy, and the ways in which cancer may be more successfully treated. https://www.benthamdirect.com/content/journals/cpd/22/16 </blockquote><br> Abbrechen
